New Drugs Shine But Biosimilars Blunt Roche Revenue Rise

 
• By Kevin Grogan
  
Vaccination
Roche is looking to soften the blow of biosimilars • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business